Dr. Arlene Siefker-Radtke, MD
Claim this profileMore about Arlene Siefker-Radtke, MD
Clinical Trial Related
19 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Arlene Siefker-Radtke, MD has experience with
- Bortezomib
- Doxorubicin
- Gemcitabine
Breakdown of trials Arlene Siefker-Radtke, MD has run
Urethral Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arlene Siefker-Radtke, MD specialize in?
Arlene Siefker-Radtke, MD focuses on Urethral Cancer and Bladder Cancer. In particular, much of their work with Urethral Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Arlene Siefker-Radtke, MD currently recruiting for clinical trials?
No, Arlene Siefker-Radtke, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Arlene Siefker-Radtke, MD has studied deeply?
Yes, Arlene Siefker-Radtke, MD has studied treatments such as Bortezomib, Doxorubicin, Gemcitabine.
What is the best way to schedule an appointment with Arlene Siefker-Radtke, MD?
Apply for one of the trials that Arlene Siefker-Radtke, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.